DPP4 Is a Potential Prognostic Marker of Thyroid Carcinoma and a Target for Immunotherapy

Gao, XQ; Le, YL; Geng, CC; Jiang, Z; Zhao, GH; Zhang, P

Zhang, P (通讯作者),Shandong Univ, Qilu Hosp Qingdao, Cheeloo Coll Med, Dept Ultrasound, Qingdao 266035, Peoples R China.;Zhang, P (通讯作者),Shandong Univ, Qilu Hosp Qingdao, Cheeloo Coll Med, Hlth Management Ctr, Qingdao 266035, Peoples R China.;Zhao, GH (通讯作者),Shandong Univ, Qilu Hosp Qingdao, Cheeloo Coll Med, Med Lab Ctr, Qingdao 266035, Peoples R China.

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2022; 2022 ():

Abstract

DPP4 (dipeptidyl peptidase 4) is expressed in many cancers, but the relationship between DPP4 and thyroid carcinoma (THCA) is incompletely understood.......

Full Text Link